Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Spectral CT was used to prospectively collect medical images and clinical data related to breast cancer, evaluate the effect of image quality in the diagnosis of breast cancer, and evaluate the application value in the accurate staging of breast cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| The application value of spectral CT in the accurate staging of breast cancer | Experimental | Prospectively collect medical images and clinical data related to breast cancer using Philips Quark CT equipment, and evaluate the diagnostic accuracy and clinical application value in the accurate staging of breast cancer. Patients diagnosed with breast cancer in Yunnan Provincial Cancer Hospital from April 2025 to May 2026 were consecutively included, and after scanning with Philips Quark CT, the TNM stage of breast cancer patients was assessed by two radiologists, and finally statistical analysis was performed. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| To explore the value of spectral CT in the diagnosis and treatment of breast cancer | Diagnostic Test | The CT scan is part of the standard treatment protocol. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pathological TNM staging | Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded | 1 day |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Caiyang Li | Contact | 13658700171 | 2020429049@kmmu.edu.cn | |
| Zhenhui Li | Contact | 13698736132 | lizhenhui@kmmu.edu.cn |
| Name | Affiliation | Role |
|---|---|---|
| Lianhua Ye | Ethics Committee of Yunnan Provincial Cancer Hospital | Study Director |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided